radiation dermatitis epidemiology forecast insight

DelveInsight’s ‘Radiation Dermatitis (RD) – Epidemiology Forecast – 2034’ report delivers an in-depth understanding of and historical and forecasted epidemiology of Radiation Dermatitis in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Radiation Dermatitis Disease Understanding

Radiation dermatitis (also called Radiodermatitis) is a condition caused by radiotherapy (X-Rays) delivered during cancer management. Pathophysiology of radiation dermatitis is a combination of radiation injury and the subsequent inflammatory response and can occur at both the irradiation entrance and exit site. Radiation dermatitis usually begins to occur within 1¬–4 weeks of treatment and persists for radiation therapy duration. It may require 2–4 weeks to heal after completion of treatment. 

Radiation dermatitis (RD) affects nearly 95% of patients who receive radiation for cancer treatment, wherein ~70% of patients have moderate-to-severe skin reactions. Certain treating drugs (termed ‘‘radiosensitizers’’) combined with radiation therapy can result in an increased incidence and severity of radiation-induced skin reactions by causing increased cellular damage and impaired cellular repair.

Radiotherapy is an essential part of cancer treatment and remains a critical and inseparable component of comprehensive cancer treatment and care. In high-income countries, radiotherapy is used in more than half of all cancer cases; these include a cure for localized disease and control disease in incurable cancers. For estimating the total cancer incidence, data regarding the incidence of various cancers were taken from country-specific total incident cases from Global Cancer Observatory (GCO) for 2018 and 2034; growth rate from 2021 to 2034 was utilized to estimate year-on-year country-specific data. Other assessments were also used to get better coverage of cancer incidence, including World Health Organization, Surveillance, Epidemiology, and End Results (SEER), International Agency for Research on Cancer, American Cancer Society, and other institutes and societies. Incidence of major cancer types such as head and neck cancer, breast, lung, prostate, colon, esophagus, and cervix were also pulled-out to show radiation therapy utilization coverage in these cancer types. These cancer types were selected based on a high incidence rate or higher radiation therapy application for treatment.

According to various research articles and Key Opinion Leader (KOL) views, Radiation Dermatitis is a major side effect of radiation exposure that exists on a continuum ranging from erythema to moist desquamation. It was estimated that nearly 95% of patients receiving radiotherapy would ultimately develop some form of radiodermatitis, including erythema, dry desquamation, and moist desquamation during or after the course of treatment. According to an article by Ryan (2012), radiation skin injury occurs in about 95% of patients receiving radiation treatment for cancer. These estimates were used to calculate the incidence of RD in the current forecast.

Radiation Dermatitis Epidemiology

The RD epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends and assumptions undertaken.

Key Findings

The total incident cases of Radiation Dermatitis patients are increasing in the 7MM during the study period, i.e., 2021-2034.

The disease epidemiology covered in the report provides historical as well as forecasted Radiation Dermatitis symptoms epidemiology segmented as the Radiotherapy Utilization, Incidence of Radiation Dermatitis, Grade-specific cases of Radiation Dermatitis, and Treated cases of Radiation Dermatitis. The report includes Radiation Dermatitis symptoms in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country-wise Radiation Dermatitis Epidemiology

The epidemiology segment also provides the Radiation Dermatitis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The total number of incident cases of Radiation Dermatitis associated in 7MM countries was 3,012,048 in 2020.

• As per the estimates, the United States has the largest incident population of Radiation Dermatitis.
• Among the EU5 countries, Germany had the highest incident cases of Radiation Dermatitis, followed by France. On the other hand, Spain had the lowest incident cases, with 151,518 cases in 2020.

Scope of the Report

• The Radiation Dermatitis report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
• The Radiation Dermatitis epidemiology report and model provide an overview of Radiation Dermatitis’s risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
• The report provides insight into Radiation Dermatitis’s historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Radiation Dermatitis.
• The report provides the Radiation Dermatitis epidemiology segmentation by radiotherapy utilization in the 7MM
• The report provides the Radiation Dermatitis epidemiology segmentation by incident cases of Radiation Dermatitis in the 7MM.
• The report provides the Radiation Dermatitis epidemiology segmentation by grade-specific cases of Radiation Dermatitis in 7MM.
• The report provides the Radiation Dermatitis epidemiology segmentation by treated cases of Radiation Dermatitis in 7MM.

Report Highlights

• 10-year Forecast of Radiation Dermatitis epidemiology
• 7MM Coverage
• Radiotherapy Utilization
• Incident Cases of Radiation Dermatitis
• Incident Cases according to segmentation: Grade-specific cases of Radiation Dermatitis
• Incident Cases according to segmentation: Treated cases of Radiation Dermatitis

KOL Views

We interview KOLs, and SMEs’ opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM for the patient population about Radiation Dermatitis?
• What are the key findings of the Radiation Dermatitis epidemiology across 7MM, and which country will have the highest number of patients during the study period (2021-2034)?
• What would be the total number of Radiation Dermatitis patients across the 7MM during the study period (2021-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the study period (2021-2034)?
• At what CAGR the patient population is expected to grow by 7MM during the study period (2021-2034)?
• What are the disease risk, burdens, and unmet needs of Radiation Dermatitis?
• What are the currently available treatments for Radiation Dermatitis?

Reasons to buy

The Radiation Dermatitis epidemiology report will allow the user to:

• Develop business strategies by understanding the trends shaping and driving the global Radiation Dermatitis market.
• Quantify patient populations in the global Radiation Dermatitis market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Radiation Dermatitis therapeutics in each of the markets covered.
• Understand the magnitude of the various cancers by radiotherapy utilization.
• Understand the magnitude of the Radiation Dermatitis population by its total incident cases.
• Understand the magnitude of the Radiation Dermatitis population by its grade-specific cases.
• Understand the magnitude of the Radiation Dermatitis population by its treated cases.
• The Radiation Dermatitis epidemiology report and model were written and developed by masters and Ph.D. level epidemiologists.
• The Radiation Dermatitis epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population